BERNA MOORE: Open Payments
NPI 1316024375 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 58 payments from 14 companies in 2025. Trend: 2023 $1,029 · 2024 $2,123 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $345 |
| LEO Pharma Inc. | 16 | $306 |
| UCB, Inc. | 3 | $178 |
| Incyte Corporation | 7 | $158 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| ABBVIE INC. | 5 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $69 |
| Arcutis Biotherapeutics, Inc. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $45 |
Products named: DUPIXENT, ADBRY, Bimzelx, OPZELURA, ANZUPGO, Zoryve, SKYRIZI, SPEVIGO.
Industry payments across CA — which companies pay providers there.
